系统性红斑狼疮临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 系统性红斑狼疮（国际通用名 systemic lupus erythematosus）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖狼疮、红斑狼疮、SLE等说法。

正在招募的系统性红斑狼疮新药试验

• Chinese Rheumatism Biobank(CRB)

  不适用招募中中国NCT06887517

• Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus

  不适用招募中SwedenNCT06166199

• Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus

  I 期 / II 期招募中中国NCT07010835

• Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases

  不适用招募中中国NCT07470151

• Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

  早期 I 期招募中中国NCT07246096

• A Study of Telitacicept in Lupus Nephritis

  II 期招募中中国NCT05680480

• The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

  I 期招募中中国NCT06285279

• Long-Term Outcomes in SLE at Peking University People's Hospital

  不适用招募中中国NCT07005479

• A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus

  II 期招募中中国NCT07299422

• NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis

  I 期招募中中国NCT06676631

• Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders

  不适用招募中美国NCT07180537

• Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE

  I 期招募中中国NCT07318259